Road to the nursing home: costs and disease progression among medicare beneficiaries with ADRD

Am J Alzheimers Dis Other Demen. 2012 Mar;27(2):90-9. doi: 10.1177/1533317512440494.

Abstract

Objectives: To estimate long-term care costs and disease progression among Medicare beneficiaries aged 65+ with ADRD.

Methods: Retrospective analysis of Medicare Part A claims and nursing home (NH) Minimum Data Set (MDS) records among beneficiaries 1999-2007. Expenditures were grouped into 3 periods; PRE, events occurring between date of ADRD diagnosis, before first NH admission; PERI, from first NH admission to at least 100 days; and, PERM, after 120 days. Utilization and reimbursements were computed for each period.

Results: Demographics of the3,681,702 ADRD beneficiaries showed average age of 83 (+/-7), female (67.7%) and white (87.4%). Medicare reimbursements per person increased by 58% from the PRE ($47,912) to PERM period ($75,654). Age, ethnicity, gender (male), and comorbidities were significantly related to total reimbursements in each phase.

Conclusions: Applying a taxonomy of NH phases, Medicare expenditures per person year are higher among patients in their terminal phase and higher still with comorbidities.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / diagnosis
  • Alzheimer Disease / economics*
  • Disease Progression
  • Female
  • Health Expenditures
  • Humans
  • Long-Term Care / economics
  • Male
  • Medicare / economics*
  • Nursing Homes / economics*
  • Retrospective Studies
  • United States